Randomised clinical trial to assess add on effect of bharangiharitaki avaleha in tamak shwasa(bronchial asthma) with special reference to eosinophil count.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- TO STUDY ADD ON EFFECT OF BHARANGIHARITAKI AVALEHA IN TAMAKA SHWASA (BRONCHIAL ASTHMA) WITH SPECIAL REFERENCE TO EOSINOPHIL COUNT
研究概览
简要总结
Bronchial asthma is the common cause of death in rural india. Patients suffering from infective respiratory diseases such as tuberculosis, pneumonia can be cured after treatment but a sizeable number of patients continue to suffer from fibrotic sequel of these diseases. Apart from these there is going to be a large group of potential respiratory patients in future. They are persons exposed to smoke, pollution and various types of occupational dust which are more prone to develop bronchial asthma and therefore constitute the group of potential respiratory patients.
​This alarming raise in the prevalence of tamak shwasa can be accounted to factors such as atmospheric pollution, rapid environmental changes, adaptation of newer dietetic preparations and tremendous psychological stress. In ayurveda it is among five types of shwasa roga, and sometimes is considered to be satisfactorily treatable disease. The clinical manifestations show high recurrence pattern.
​Therefore, the management criteria should be addressed to quality improvement in the life of patients.
​Ayurveda can give promising result to the patient either by adding rasayana and thus enhancing the vital capacity and resistance of the lung or can be adjuvant to present modern regimen for the management of tamaka shwasa by the quality of life of affected patients, this drug having ushna tikta and shwassthan karma may affect and reduces the symptoms and dose of ongoing drugs.
​Vata and kapha are the two key pathological factors involved in the samprapti of tamaka shwasa. Thus, more and more research work is the need of the day either in bringing about a cure for this illness or effective control. More than 200 works have been carried out on this topic in all over India in ayurveda field. Ayurveda has got many time-tested formulations for this condition.
​Clinically, patient’s eosinophil count and respiratory rate is increased, peak expiratory flow rate is lower. According to line of treatment of tamaka shwasa,so topic is selected bharangiharitaki avaleha which is having vata-kaphaghna and ushna property, any decrease in symptoms i.e. eosinophil count, respiratory rate and peak expiratory flow rate will be observed. The present study will be carried out to study add on effect of bharangiharitaki avaleha in tamak shwasa.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient having tamak shwasa symptoms like shwasakrichtta, kasa(cough) lalate sweda (sweating over forehead, asinolabhate saukhyam (comfortable in sitting position), vamathu prayaha (spitting again and again), anidra (insommnia) 2) Patient in avega avastha.
- •Patient on drug etofylline (23 mg) + theophylline (77 mg) BD 4) Sex: irrespective of sex 5) Patient of age group 18-50 will be included.
排除标准
- •Patient with bronchiectectasis, emphysema, infective neoplasmic disease of Respiration.
- •Known case of tamak shwasa taking treatment more than 3 years.
- •Patient on drug other than etofylline (23 mg) + theophylline (77 mg) BD.
- •Patient with systemic disorder.
- •Patient in vega avasta.
- •Pregnancy, Lactating Mother.
结局指标
主要结局
TO STUDY ADD ON EFFECT OF BHARANGIHARITAKI AVALEHA IN TAMAKA SHWASA (BRONCHIAL ASTHMA) WITH SPECIAL REFERENCE TO EOSINOPHIL COUNT
时间窗: 30 days
次要结局
- 1) To study tamak shwasa according to ayurvedicliterature.(2) To study bronchial asthma.)
研究者
Dr Namrata Jayprakash shinde
LRP Ayurvedic Medical College and Hospital